Venlafaxine Hydrochloride
"Venlafaxine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
| Descriptor ID |
D000069470
|
| MeSH Number(s) |
D02.033.415.510.500.901 D02.092.471.683.948 D02.455.426.392.368.367.318.750 D10.289.510.500.901
|
| Concept/Terms |
Venlafaxine Hydrochloride- Venlafaxine Hydrochloride
- Hydrochloride, Venlafaxine
- Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
- 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl
Wy 45030- Wy 45030
- Wy-45030
- Wy45030
- Wy-45,030
- Wy 45,030
- Wy45,030
Effexor- Effexor
- Trevilor
- Vandral
- Efexor
|
Below are MeSH descriptors whose meaning is more general than "Venlafaxine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Venlafaxine Hydrochloride".
This graph shows the total number of publications written about "Venlafaxine Hydrochloride" by people in this website by year, and whether "Venlafaxine Hydrochloride" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 6 | 6 |
| 2015 | 2 | 2 | 4 |
| 2016 | 2 | 3 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Venlafaxine Hydrochloride" by people in Profiles.
-
Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial. J Affect Disord. 2024 Sep 15; 361:651-658.
-
QRS Prolongation After Seizure in a Patient with Venlafaxine Overdose. J Emerg Med. 2024 01; 66(1):e38-e40.
-
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis. J Affect Disord. 2023 10 15; 339:691-697.
-
Periodic leg movements during sleep associated with antidepressants: A meta-analysis. Neurosci Biobehav Rev. 2023 05; 148:105126.
-
Management of Menopausal Symptoms: A Review. JAMA. 2023 02 07; 329(5):405-420.
-
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2022 05 31; 52(2):45-72.
-
Transcranial Magnetic Stimulation Indices of Cortical Excitability Enhance the Prediction of Response to Pharmacotherapy in Late-Life Depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 03; 7(3):265-275.
-
Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy. J Psychiatry Neurosci. 2021 01 04; 46(1):E88-E96.
-
Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study. Chest. 2020 08; 158(2):765-775.
-
Seizure in venlafaxine overdose: a 10-year retrospective review of the California poison control system. Clin Toxicol (Phila). 2020 10; 58(10):984-990.